2,200 Is Minimum Number of Daily Steps Needed to Lower Death, CVD Risk
By Lori Solomon HealthDay Reporter
FRIDAY, March 15, 2024 -- Any amount of activity above 2,200 steps per day is associated with lower mortality and cardiovascular disease (CVD) risk, regardless of sedentary time, according to a study published online March 5 in the British Journal of Sports Medicine.
Matthew N. Ahmadi, from University of Sydney, and colleagues examined associations between daily step count and all-cause mortality and incident CVD by sedentary time levels. Analysis included data from 72,174 older participants in the U.K. Biobank followed for 6.9 years.
The researchers found that compared to a reference of 2,200 steps/day (fifth percentile), the optimal dose (nadir of the curve) for all-cause mortality ranged between 9,000 and 10,500 steps/day for high (hazard ratio [HR], 0.61) and low (HR, 0.69) sedentary time. There was a subtle gradient of association by sedentary time level with the lowest risk of incident CVD observed at approximately 9,700 steps/day for high (HR, 0.79) and low (HR, 0.71) sedentary time. Across sedentary time groups, the minimal dose (steps/day associated with 50 percent of the optimal dose) of daily steps was between 4,000 and 4,500 steps/day for all-cause mortality and incident CVD.
"For a roughly equivalent number of steps/day, the risk of incident CVD was lower for low sedentary time compared with high sedentary time," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023
WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...
Overall Burden of CVD Remained High in United Kingdom in 2000 to 2019
THURSDAY, June 27, 2024 -- The overall burden of cardiovascular disease (CVD) remained high during 2000 to 2019 in the United Kingdom, according to a study published online June...
hs-cTnT Linked to MACE, Mortality in Rheumatoid Arthritis
THURSDAY, June 27, 2024 -- For patients with rheumatoid arthritis (RA), a detectable level of high-sensitivity cardiac troponin T (hs-cTnT) is associated with increased risk of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.